Kite Takeover by Gilead Lifts Biotech Stocks

 | Aug 28, 2017 | 10:55 AM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

kite

,

gild

,

IWM

,

juno

,

blcm

,

blue

,

immu

,

spxs

,

spxs

A takeover of Kite Pharmaceuticals (KITE) by Gilead Sciences (GILD) is boosting the biotechnology sector across the board and that is providing some support, particularly for the Nasdaq. Breadth is running about even, but the S&P 500 is lagging and the Russell2000 ETF (IWM) was sold sharply after gaping up.

Biotechnology is typically a good group for leadership, as it tends to be more speculative and shows that there is an appetite for risk. In this case, it doesn't look like the group has coattails. Traders are trying to catch some quick sympathy moves in names like Juno Therapeutics (JUNO) , Bellcum (BLCM) , Bluebird Biotech (BLUE) , Immunomedics (IMMU) and others.

Outside of the biotechnology group, I continue to dislike the action I am seeing in individual stocks. There just isn't much on my radar. I've added to an index short in the form of Direxion Daily S&P Bear 3X (SPXS) and will build that further on intraday lows.

The key to dealing with this environment is to keep an open mind, stay patient and not force things. While I have a negative bias at the moment, I will be happy to change my mind and build some long positions if the chart develops.

Columnist Conversations

Facebook had outstanding earnings and looks to continue upward, while HD is a strong breakout on volume and Ak...
Stock picking contests can be entertaining and can provide some interesting ideas but if you seriously want to...
Your Reality Check. Check out Real Money's Helene Meisler's latest podcast here. Subscribe to Meisler's T...
XBTUSD (Bitcoin) On 4/25 Bitcoin top ticked @ 9755.52 and then FELL. Our first short term support @ 8990 was...

BEST IDEAS

REAL MONEY'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.